MANA Therapeutics

BiotechnologySeries AArlington, USmanatherapeutics.com

Latest round

Series A

Last raised

Jan 2021

Total raised

$35M

Investors

3

About MANA Therapeutics

MANA Therapeutics, Inc.Founded in 2018 and headquartered in Arlington, US, MANA Therapeutics focuses on cell therapy innovations.0 mn. The company was established by C.MANA Therapeutics develops next-generation cell therapies targeting various health conditions. The company aims to expand its market presence and is targeting new therapeutic areas and geographic regions for its products, although specific markets and timelines have not been disclosed.

Who invested in MANA Therapeutics

3 investors across 2 rounds

See all investors in MANA Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 8, 2021

    Amount

    $35M

    Investors

    Locked

  2. Seed

    Oct 18, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about MANA Therapeutics

Who invested in MANA Therapeutics?

MANA Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has MANA Therapeutics raised?

MANA Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did MANA Therapeutics last raise money?

MANA Therapeutics's most recent round on record is a Series A, in Jan 2021.

What does MANA Therapeutics do?

MANA Therapeutics is a biotechnology company.

Where is MANA Therapeutics headquartered?

MANA Therapeutics is headquartered in Arlington, US.

Which VCs invest in companies like MANA Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at MANA Therapeutics's stage. Their profiles are linked below.

Raising like MANA Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.